Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by Just2017on Dec 30, 2017 9:43pm

119 Views

Post# 27253113

Recommendation to any sources with quick Marijuana news

I know this may not be specific to NF, but I am sure alot of you are invested in multiple marijuana stocks.

I was wondering if any one has site similar to mining (https://www.juniorminingnetwork.com), where they would provide quick updates on marijana NR from any company in this sector.

Thanks you very much

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property